BCWM
BNTX icon

Bartlett & Co Wealth Management’s BioNTech BNTX Stock Holding History

Bartlett & Co Wealth Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-650
Closed -$81K – 1156
2023
Q1 		$81K Hold
650
– – ﹤0.01% 495
2022
Q4 		$97.6K Hold
650
– – ﹤0.01% 474
2022
Q3 		$87.7K Buy
+650
New +$99.4K ﹤0.01% 474

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bartlett & Co Wealth Management's BNTX Position: Q2 2023 in Review

Bartlett & Co Wealth Management sold out of BioNTech (BNTX) in Q2 2023, closing a stake of 650 shares — an estimated $81K sold.

Bartlett & Co Wealth Management first reported a position in BNTX in Q3 2022 and held it in 3 quarters. The position peaked at $97.6K in Q4 2022. 253 funds tracked by Wall St. Rank hold BNTX as of Q2 2023.

  • Bartlett & Co Wealth Management reported no remaining BioNTech position as of Q2 2023 after selling out during the quarter.
  • Bartlett & Co Wealth Management sold 650 BioNTech shares in Q2 2023, an estimated $81K.
  • Bartlett & Co Wealth Management first reported a position in BioNTech in Q3 2022 and held it in 3 quarters.
  • Bartlett & Co Wealth Management's BioNTech position peaked at $97.6K in Q4 2022.
  • 253 funds tracked by Wall St. Rank held BioNTech as of Q2 2023.

Based on Bartlett & Co Wealth Management's 13F filing for Q2 2023, filed 14 Feb 2024.